Filters

Ambrisentan manufacturers

10 products found

Filters

ambrisentan

Tablets, film coated 2.5mg, 5mg, 10mg

Dossier type
EU CTD
Country of origin
European Union
Dossier status
Ready
GMP approvals
EU GMP

ambrisentan

Tablets, film coated 5mg, 10mg

Dossier type
EU CTD
Country of origin
European Union
Dossier status
Ready
GMP approvals
EU GMP

ambrisentan

Tablets 5mg, 10mg

Dossier type
US CTD
Country of origin
United States
Dossier status
Ready
GMP approvals
FDA

ambrisentan

Tablets, film coated 5mg, 10mg

Dossier type
CTD
Country of origin
Argentina
Dossier status
Ready
GMP approvals
Argentina

ambrisentan

Tablets 5mg,10mg

Dossier type
CTD
Country of origin
India
Dossier status
Ready
GMP approvals
WHO

ambrisentan

Tablets 5 mg

Dossier type
CTD
Country of origin
Bangladesh
Dossier status
Ready
GMP approvals
United Kingdom

ambrisentan

Tablets 5 mg

Dossier type
CTD
Country of origin
Argentina
Dossier status
Ready
GMP approvals
PICS

ambrisentan

Tablets 5 mg, 10 mg

Dossier type
CTD
Country of origin
India
Dossier status
Ready
GMP approvals
WHO

ambrisentan

Tablets 5 mg, 10 mg

Dossier type
CTD
Country of origin
India
Dossier status
Ready
GMP approvals
WHO

ambrisentan

Tablets 5 mg, 10 mg

Dossier type
CTD
Country of origin
Argentina
Dossier status
Ready
GMP approvals
PICS

What is the Ambrisentan drug?

Ambrisentan is an endothelin receptor antagonist. Ambrisentan will act by relaxing the muscles that are constricted in blood vessels by the peptide endothelin and causing blood pressure. Ambrisentan drug is used to treat PAH (Pulmonary Artery Hypertension); it means high blood pressure in the lungs. Taking Ambristentan medicine is not only to treat pulmonary hypertension but also to improve the exercise ability of the patient.
The FDA approved Ambrisentan in 2007 and the European Medicines Agency. It is considered as an orphan drug.

Ambrisentan manufacturers and wholesalers:

Ambrisentan is known under different brand names; probably, the most known is Letairis from the manufacturer Gilead in the US. In the EU, the brand name is Volibris, in India Pulmonext by the MSN Labs, Ambrican by Lupin, Endobloc by Cipla Ltd, and in Germany, the brand name is Zambri by German Remedies Ltd.
The FDA approved the Ambrisentan generic to four manufacturers: Mylan Pharmaceuticals, Watson Laboratories, Sun Pharma Global, and Zydus Pharmaceuticals. The Ambrisentan drug is found globally.
Ambrisentan suppliers market it in the form of oral tablets of 5 mg and 10 mg.

Ambrisentan for sales:

In the US, Ambrisentan under the name Letairis can cost from $233.27 to $258.55 per oral tablet of 5 mg or 10mg. In France, Ambrisentan, under the name Volibris, costs around 72 € without tax per tablet.
As Ambrisentan is available globally, fraudulent online pharmacies may attempt to sell an illegal generic version of Ambrisentan. Thanks to Pipelinepharma online marketplace, you can be sure of the qualifications of the sellers because they all have been through quality control procedures. Plus, being sure your future partner is qualified, you will save time sourcing for the product and buyer or seller, because it is all in one safe place: Pipelinepharma B2B marketplace. On the platform, you can easily place orders for any pharmaceutical products, including Ambrisentan. From our online marketplace, Ambrisentan is mostly available from the European Union (the Czech Republic and Greece) and Argentina.

How to use Ambrisentan drugs?

To treat PAH, an adult should take the initial dose of 5 mg of Ambrisentan orally once a day. A pregnant woman or a woman who is planning to get pregnant should avoid at all costs taking the Ambrisentan drug because it can cause severe birth defects.
Taking Ambrisentan can have some side effects, the most common ones are: bloating or swelling of the face, arms, hands, lower legs, or feet, rapid weight gain, tingling of the hands or feet, unusual weight gain or loss.